Ben R. Taylor
Chief Financial Officer · RECURSION PHARMACEUTICALS, INC.
- 2024
- Sep 16, 2026
- 14
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ben R. Taylor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Blake Borgeson - $3.38M in RXRX purchases and sales in the last 12 months
- Christopher Gibson - $2.41M in RXRX purchases and sales in the last 12 months
- Najat Khan - $258K in RXRX purchases and sales in the last 12 months
- Robert Hershberg - $125K in RXRX purchases and sales in the last 12 months
- Namandje Bumpus - $28K in RXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ben R. Taylor?
Ben R. Taylor is a corporate insider, tracked as Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ben R. Taylor submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Ben R. Taylor been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($68K) across all tracked filings.
